<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013035</url>
  </required_header>
  <id_info>
    <org_study_id>2015.01.01</org_study_id>
    <nct_id>NCT04013035</nct_id>
  </id_info>
  <brief_title>Cervical Length on Pregnancy Termination</brief_title>
  <official_title>The Impact of Fetal Viability and Cervical Length on Pregnancy Termination Outcomes in Nulliparous Second Trimester Pregnancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cervical length is used as a parameter to predict cervical insufficiency and onset of labor.
      However, its role in predicting abortion induction is unclear.To investigate the impact of
      cervical length measurement and fetal viability on second trimester pregnancy termination
      duration in nulliparous pregnant women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cervical length and fetal viability were evaluated prior to second trimester pregnancy
      termination due to various indications. nulliparous pregnant women through 13 and 26
      gestational weeks in whom pregnancy termination was conducted within 72 hours after admission
      were included in the study. The subjects were grouped into two groups according to fetal
      viability.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">June 1, 2017</completion_date>
  <primary_completion_date type="Actual">June 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cervical length measurement</measure>
    <time_frame>2 days</time_frame>
    <description>cervical length measurement at second trimester pregnancy termination in nulliparous pregnant women. The measurements will be saved as a number in cm.</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Pregnancy Loss</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cervical length measurement</intervention_name>
    <description>cervical length measurement at second trimester pregnancy termination in nulliparous pregnant women.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Nulliparous pregnant women at 13-26 weeks of gestation will be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Nulliparous pregnant women at 13-26 weeks of gestation

        Exclusion Criteria:

          -  Patients with multiple gestations,

          -  multiparous patients or

          -  patients that had uterine gynecologic surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kanuni Sultan Süleyman Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>33404</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 7, 2019</study_first_submitted>
  <study_first_submitted_qc>July 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Pınar Kadirogulları</investigator_full_name>
    <investigator_title>principal investigator, M.D, Department of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>Cervix</keyword>
  <keyword>Length</keyword>
  <keyword>Viability</keyword>
  <keyword>prostaglandin</keyword>
  <keyword>Termination</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

